Glomerular Diseases : Impact Factor & More
eISSN: 2673-3633
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Glomerular Diseases Journal Specifications
Indexed in the following public directories
DOAJ
| Overview | |
| Publisher | Karger Publishers |
| Language | English |
| Article Processing Charges | USD 990 | EUR 850 | CHF 920 |
| Publication Time | 24 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 24 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Glomerular Diseases ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Glomerular Diseases
An “All-in-One” Kidney Biopsy in AIDS: Crescentic Immune Complex–Mediated Glomerulonephritis, CD8-Driven Interstitial Nephritis, and Superimposed Thrombotic Microangiopathy
- 4 May 2026
- Glomerular Diseases
Clinical Remission as a Function of Exposure to Cyclophosphamide in Patients with Primary Membranous Nephropathy: A One-Year Cohort Study
- 7 Apr 2026
- Glomerular Diseases
Clinical Outcome Assessment Endpoints in Nephrotic Syndrome Drug Development: Research Partner Feedback on Patient-Centered Trial Design
- 7 Apr 2026
- Glomerular Diseases
Nudging Nephrologists in Cardiovascular Risk Assessment and Management in Glomerular Diseases Treated with Immunosuppressants: An Implementation Study
- 23 Mar 2026
- Glomerular Diseases
Serum Phospholipase A2 Receptor Antibody Is Associated with Thrombogenesis in Primary Membranous Nephropathy: A Systematic Review and Meta-Analysis
- 19 Mar 2026
- Glomerular Diseases
Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits: An Immunologic Crossroads
- 12 Mar 2026
- Glomerular Diseases
An “All-in-One” Kidney Biopsy in AIDS: Crescentic Immune Complex–Mediated Glomerulonephritis, CD8-Driven Interstitial Nephritis, and Superimposed Thrombotic Microangiopathy
- 4 May 2026
- Glomerular Diseases
Clinical Remission as a Function of Exposure to Cyclophosphamide in Patients with Primary Membranous Nephropathy: A One-Year Cohort Study
- 7 Apr 2026
- Glomerular Diseases
Clinical Outcome Assessment Endpoints in Nephrotic Syndrome Drug Development: Research Partner Feedback on Patient-Centered Trial Design
- 7 Apr 2026
- Glomerular Diseases
Nudging Nephrologists in Cardiovascular Risk Assessment and Management in Glomerular Diseases Treated with Immunosuppressants: An Implementation Study
- 23 Mar 2026
- Glomerular Diseases
Serum Phospholipase A2 Receptor Antibody Is Associated with Thrombogenesis in Primary Membranous Nephropathy: A Systematic Review and Meta-Analysis
- 19 Mar 2026
- Glomerular Diseases
Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits: An Immunologic Crossroads
- 12 Mar 2026
- Glomerular Diseases
FAQs on Glomerular Diseases
How many articles did Glomerular Diseases publish last year? 
Who is the publisher of Glomerular Diseases?
